you are here:

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals

BSE Live

Apr 09, 16:00
636.95 22.65 (3.69%)
Volume
AVERAGE VOLUME
5-Day
396,190
10-Day
268,679
30-Day
311,711
886,467
  • Prev. Close

    614.30

  • Open Price

    615.00

  • Bid Price (Qty.)

    636.95 (50)

  • Offer Price (Qty.)

    636.95 (695)

NSE Live

Apr 09, 15:59
636.75 22.50 (3.66%)
Volume
AVERAGE VOLUME
5-Day
7,506,826
10-Day
6,394,829
30-Day
6,307,160
16,755,446
  • Prev. Close

    614.25

  • Open Price

    613.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    636.75 (2197)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 11,906.74 9,783.29 8,774.41 7,509.67 7,262.46  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 109.24 130.43  
Revenue From Operations [Net] 11,906.74 9,783.29 8,774.41 7,400.43 7,132.03  
Total Operating Revenues 12,531.93 10,303.21 9,006.25 7,683.96 7,614.46  
Other Income 1,510.92 1,271.44 1,128.04 515.08 431.82  
Total Revenue 14,042.85 11,574.65 10,134.29 8,199.04 8,046.28  
EXPENSES  
Cost Of Materials Consumed 3,201.71 2,727.71 2,210.12 2,228.45 2,019.85  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade 138.60 -251.30 159.26 -167.86 -68.48  
Employee Benefit Expenses 1,702.77 1,571.34 1,625.00 1,499.88 1,480.51  
Finance Costs 408.01 540.92 388.31 223.57 530.64  
Depreciation And Amortisation Expenses 561.56 552.95 487.24 422.28 463.98  
Other Expenses 3,549.79 3,302.35 2,832.10 2,773.02 3,447.56  
Total Expenses 10,789.85 9,640.82 8,903.54 8,215.84 9,044.06  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 3,253.00 1,933.83 1,230.75 -16.80 -997.78  
Exceptional Items 0.00 -1,214.38 -950.50 0.00 -70.13  
Profit/Loss Before Tax 3,253.00 719.45 280.25 -16.80 -1,067.91  
Tax Expenses-Continued Operations  
Current Tax 386.46 1.55 2.02 5.77 5.45  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -344.60 -98.70 -27.41 0.27 0.00  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 41.86 -97.15 -25.39 6.04 5.45  
Profit/Loss After Tax And Before ExtraOrdinary Items 3,211.14 816.60 305.64 -22.84 -1,073.36  
Profit/Loss From Continuing Operations 3,211.14 816.60 305.64 -22.84 -1,073.36  
Profit/Loss For The Period 3,211.14 816.60 305.64 -22.84 -1,073.36  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 13.40 3.40 1.30 -0.10 -4.50  
Diluted EPS (Rs.) 13.40 3.40 1.30 -0.10 -4.50  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 823.35  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 1,196.50  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 77.34  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 283.04  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 1,378.96 479.16 797.74 240.68 240.68  
Tax On Dividend 192.89 0.56 0.34 7.47 7.47  
Equity Dividend Rate (%) 400.00 275.00 200.00 350.00 100.00  
Source : Dion Global Solutions Limited